FindTrial
Sign In

Development of a mobile application and the effectiveness of a brief asynchronous mindfulness and self-compassion intervention for cases of Anxiety, Stress and Depression

Development of a mobile application and the effectiveness of a brief asynchronous mindfulness and self-compassion intervention for cases of Anxiety, Stress and Depression in university students and teachers of basic education: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-2fs9kms
Enrollment
Unknown
Registered
2023-09-18
Start date
2024-03-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress, Psychological

Interventions

This is a randomized, controlled, non-blinded, waiting list controlled trial, involving Brazilian adults, which aims to examine the effectiveness of a brief mindfulness and self-compassion interventio
F02.463.551.500

Sponsors

Centro de Ciências Humanas, Letras e Artes - Universidade Federal da Paraíba
Lead Sponsor
Centro de Ciências Humanas, Letras e Artes - Universidade Federal da Paraíba
Collaborator

Eligibility

Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Study 1: be between the ages of 18 and 65; both genders; be Brazilian; being a basic education teacher; have internet access and a cell phone with Android system; be willing to download and use the application; achieving a score greater than 0 on symptoms of depression, anxiety, and stress measured by subscales of the Depression, Anxiety, and Stress Scale (DASS-21) (Vignola & Tucci, 2014). Study 2: be between the ages of 18 and 35; both genders; be Brazilian; be a university student (undergraduate or graduate); have internet access and a cell phone with Android system; be willing to download and use the application; achieving a score greater than 0 on symptoms of depression, anxiety, and stress measured by subscales of the Depression, Anxiety, and Stress Scale (DASS-21) (Vignola & Tucci, 2014)

Exclusion criteria

Exclusion criteria: Studies 1 and 2: already adopting a frequent mindfulness practice in the last 6 months; be using some type of psychotropic medication; being under psychological treatment; have a diagnosis of psychiatric or neurological illness (eg, schizophrenia, borderline personality disorder); not have or be willing to create a Gmail account

Design outcomes

Primary

MeasureTime frame
As a primary outcome, it is expected that there will be a statistically significant decrease in the levels of anxiety, stress and depression measured by the Depression, Anxiety and Stress Scale (DASS-21).—

Secondary

MeasureTime frame
As a secondary outcome, it is expected that there will be a statistically significant increase in the levels of mindfulness and self-compassion measured respectively by the Five Facets of Mindfulness Questionnaire (FFMQ-BR) and by the Self-Compassion Scale (SCS-BR).—

Countries

Brazil

Contacts

Public ContactLeonardo Silva

Universidade Federal da Paraíba - UFPB

leonardojuniorsouzasilva@gmail.com+55(83)3048-8517

Outcome results

None listed

Source: REBEC (via WHO ICTRP)